ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE




Ruya Abdulaziz A Althomali , Renad Ibrahim Aloqayli , Basma Walid Ahmad Alyafi , Ahela Faisal Abdulaziz Nono , Suhaib Saleh Alkhalaf , Abdulaziz Abdullah Aljomailan , Hesham Mohammed ALHarbi , Abdulrahman Mohammed Qadah Alqahtani , Hawra shokri Alherz , Moluk Nabeel Aldebani


Introduction: 80% of healthy neonates present with some degree of hyperbilirubinemia after birth, however, only 5- 10% would require therapy to prevent damage or treat the cause of jaundice. Neonatal jaundice can be classified as physiological and pathological and can have several causes such as breast milk feeding, blood group incompatibility, hemolysis, or genetic defects of enzymes in the bilirubin metabolism pathway. Aim of the work: we tried to understand the various types of neonatal jaundice, and also focus on its management. Methodology: we conducted this review using a comprehensive search of MEDLINE, PubMed and EMBASE from January 2001 to March 2017. The following search terms were used: neonatal jaundice, hyperbilirubinemia, ABO incompatibility, neonatal hemolysis, kernicterus, phototherapy, exchange transfusion Conclusion: Hyperbilirubinemia and jaundice are common issues encountered neonates and infants. Most cases of neonatal hyperbilirubinemia and jaundice are physiological and benign. However, some severe cases may progress to develop severe and permanent long-term complications. Therefore, early diagnosis and management is essential. Neonatal jaundice can be treated using phototherapy, pharmacological agents, intravenous immunoglobulins, amd exchange transfusion in severe cases. Keywords: neonatal jaundice, neonatal hyperbilirubinemia, prematurity, kernicterus


  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.